Related Experiment Videos
Transglutaminase activity and embryonal carcinoma cell differentiation
Experimental Cell Biology
|January 1, 1987
Summary
Retinoic acid (RA) triggers differentiation in mouse embryonal carcinoma (EC) cells by modulating transglutaminase (TGase) activity. Inhibiting TGase blocks this RA-induced differentiation, suggesting TGase is crucial for the process.
Area of Science:
- Cell biology
- Biochemistry
- Developmental biology
Background:
- Embryonal carcinoma (EC) cells are pluripotent stem cells.
- Retinoic acid (RA) is a key inducer of differentiation in EC cells.
- Transglutaminase (TGase) is an enzyme involved in various cellular processes.
Purpose of the Study:
- To investigate the role of transglutaminase (TGase) in retinoic acid (RA) induced differentiation of murine embryonal carcinoma (EC) cells.
Main Methods:
- Murine EC cells were treated with retinoic acid (RA).
- Transglutaminase (TGase) activity was measured following RA exposure.
- The effect of TGase inhibitors on RA-induced differentiation was assessed in vitro.
Main Results:
- Retinoic acid (RA) treatment rapidly modulated transglutaminase (TGase) activity in EC cells.
- Inhibition of TGase activity in vitro blocked RA-induced EC cell differentiation.
- These findings indicate a direct correlation between TGase activity and EC cell differentiation.
Conclusions:
- Transglutaminase (TGase) activity is modulated early in the retinoic acid (RA) induced differentiation of murine embryonal carcinoma (EC) cells.
- TGase plays a significant role in mediating RA-induced EC cell differentiation.
- Targeting TGase may offer a novel strategy for controlling EC cell differentiation.